nodes	percent_of_prediction	percent_of_DWPC	metapath
Amobarbital—Atelectasis—Everolimus—kidney cancer	0.0379	0.045	CcSEcCtD
Amobarbital—Pneumothorax—Pazopanib—kidney cancer	0.0314	0.0373	CcSEcCtD
Amobarbital—Pneumothorax—Everolimus—kidney cancer	0.0248	0.0295	CcSEcCtD
Amobarbital—Pneumothorax—Sunitinib—kidney cancer	0.0207	0.0246	CcSEcCtD
Amobarbital—Pneumothorax—Paclitaxel—kidney cancer	0.0139	0.0165	CcSEcCtD
Amobarbital—Hypoxia—Gemcitabine—kidney cancer	0.013	0.0155	CcSEcCtD
Amobarbital—Dermatitis exfoliative—Temsirolimus—kidney cancer	0.0128	0.0152	CcSEcCtD
Amobarbital—Hepatocellular injury—Everolimus—kidney cancer	0.0124	0.0147	CcSEcCtD
Amobarbital—Hepatocellular injury—Erlotinib—kidney cancer	0.0119	0.0142	CcSEcCtD
Amobarbital—Pneumothorax—Capecitabine—kidney cancer	0.0114	0.0136	CcSEcCtD
Amobarbital—Respiratory failure—Sunitinib—kidney cancer	0.0105	0.0125	CcSEcCtD
Amobarbital—Depressed level of consciousness—Sunitinib—kidney cancer	0.00996	0.0118	CcSEcCtD
Amobarbital—Dermatitis exfoliative—Everolimus—kidney cancer	0.0095	0.0113	CcSEcCtD
Amobarbital—Respiratory failure—Vincristine—kidney cancer	0.00889	0.0106	CcSEcCtD
Amobarbital—Respiratory failure—Gemcitabine—kidney cancer	0.00843	0.01	CcSEcCtD
Amobarbital—Dermatitis exfoliative—Sorafenib—kidney cancer	0.00825	0.0098	CcSEcCtD
Amobarbital—Injection site reaction—Gemcitabine—kidney cancer	0.00823	0.00977	CcSEcCtD
Amobarbital—Bradycardia—Pazopanib—kidney cancer	0.008	0.0095	CcSEcCtD
Amobarbital—Thinking abnormal—Paclitaxel—kidney cancer	0.00757	0.00899	CcSEcCtD
Amobarbital—Pneumothorax—Doxorubicin—kidney cancer	0.00737	0.00875	CcSEcCtD
Amobarbital—Respiratory failure—Paclitaxel—kidney cancer	0.00706	0.00838	CcSEcCtD
Amobarbital—Injection site reaction—Paclitaxel—kidney cancer	0.00689	0.00818	CcSEcCtD
Amobarbital—Angioedema—Temsirolimus—kidney cancer	0.00663	0.00788	CcSEcCtD
Amobarbital—Hallucination—Everolimus—kidney cancer	0.00617	0.00733	CcSEcCtD
Amobarbital—Anxiety—Temsirolimus—kidney cancer	0.00616	0.00731	CcSEcCtD
Amobarbital—Syncope—Pazopanib—kidney cancer	0.00613	0.00728	CcSEcCtD
Amobarbital—Mental disability—Paclitaxel—kidney cancer	0.00602	0.00714	CcSEcCtD
Amobarbital—Loss of consciousness—Pazopanib—kidney cancer	0.00601	0.00714	CcSEcCtD
Amobarbital—Ataxia—Vincristine—kidney cancer	0.00596	0.00707	CcSEcCtD
Amobarbital—Injection site reaction—Capecitabine—kidney cancer	0.00566	0.00671	CcSEcCtD
Amobarbital—Depressed level of consciousness—Capecitabine—kidney cancer	0.00549	0.00652	CcSEcCtD
Amobarbital—Shock—Pazopanib—kidney cancer	0.00549	0.00652	CcSEcCtD
Amobarbital—Dermatitis exfoliative—Paclitaxel—kidney cancer	0.00533	0.00633	CcSEcCtD
Amobarbital—Bradycardia—Sunitinib—kidney cancer	0.00528	0.00626	CcSEcCtD
Amobarbital—Somnolence—Temsirolimus—kidney cancer	0.00527	0.00625	CcSEcCtD
Amobarbital—Constipation—Temsirolimus—kidney cancer	0.00507	0.00602	CcSEcCtD
Amobarbital—Agitation—Everolimus—kidney cancer	0.00496	0.00589	CcSEcCtD
Amobarbital—Somnolence—Pazopanib—kidney cancer	0.00496	0.00589	CcSEcCtD
Amobarbital—Mental disability—Capecitabine—kidney cancer	0.00494	0.00586	CcSEcCtD
Amobarbital—Angioedema—Everolimus—kidney cancer	0.00493	0.00586	CcSEcCtD
Amobarbital—Syncope—Everolimus—kidney cancer	0.00484	0.00575	CcSEcCtD
Amobarbital—Loss of consciousness—Everolimus—kidney cancer	0.00475	0.00564	CcSEcCtD
Amobarbital—Ataxia—Paclitaxel—kidney cancer	0.00473	0.00562	CcSEcCtD
Amobarbital—Body temperature increased—Temsirolimus—kidney cancer	0.00468	0.00556	CcSEcCtD
Amobarbital—Syncope—Erlotinib—kidney cancer	0.00467	0.00555	CcSEcCtD
Amobarbital—Anxiety—Everolimus—kidney cancer	0.00458	0.00544	CcSEcCtD
Amobarbital—Loss of consciousness—Erlotinib—kidney cancer	0.00458	0.00544	CcSEcCtD
Amobarbital—Anxiety—Erlotinib—kidney cancer	0.00442	0.00525	CcSEcCtD
Amobarbital—Dermatitis exfoliative—Capecitabine—kidney cancer	0.00438	0.0052	CcSEcCtD
Amobarbital—Hypersensitivity—Temsirolimus—kidney cancer	0.00437	0.00518	CcSEcCtD
Amobarbital—Hallucination—Vincristine—kidney cancer	0.00436	0.00518	CcSEcCtD
Amobarbital—Liver injury—Doxorubicin—kidney cancer	0.00436	0.00517	CcSEcCtD
Amobarbital—Shock—Everolimus—kidney cancer	0.00434	0.00515	CcSEcCtD
Amobarbital—Angioedema—Sorafenib—kidney cancer	0.00428	0.00509	CcSEcCtD
Amobarbital—Syncope—Sorafenib—kidney cancer	0.0042	0.00499	CcSEcCtD
Amobarbital—Shock—Erlotinib—kidney cancer	0.00418	0.00497	CcSEcCtD
Amobarbital—Angioedema—Sunitinib—kidney cancer	0.00412	0.00489	CcSEcCtD
Amobarbital—Loss of consciousness—Sorafenib—kidney cancer	0.00412	0.00489	CcSEcCtD
Amobarbital—Hypotension—Everolimus—kidney cancer	0.00412	0.00489	CcSEcCtD
Amobarbital—Thinking abnormal—Doxorubicin—kidney cancer	0.00401	0.00476	CcSEcCtD
Amobarbital—Somnolence—Everolimus—kidney cancer	0.00392	0.00465	CcSEcCtD
Amobarbital—Dizziness—Temsirolimus—kidney cancer	0.00392	0.00465	CcSEcCtD
Amobarbital—Ataxia—Capecitabine—kidney cancer	0.00388	0.00461	CcSEcCtD
Amobarbital—Constipation—Vinblastine—kidney cancer	0.00378	0.00449	CcSEcCtD
Amobarbital—Constipation—Everolimus—kidney cancer	0.00377	0.00448	CcSEcCtD
Amobarbital—Vomiting—Temsirolimus—kidney cancer	0.00377	0.00447	CcSEcCtD
Amobarbital—Shock—Sorafenib—kidney cancer	0.00376	0.00447	CcSEcCtD
Amobarbital—Rash—Temsirolimus—kidney cancer	0.00374	0.00444	CcSEcCtD
Amobarbital—Dermatitis—Temsirolimus—kidney cancer	0.00373	0.00443	CcSEcCtD
Amobarbital—Headache—Temsirolimus—kidney cancer	0.00371	0.00441	CcSEcCtD
Amobarbital—Dizziness—Pazopanib—kidney cancer	0.00369	0.00438	CcSEcCtD
Amobarbital—Hepatocellular injury—Doxorubicin—kidney cancer	0.00367	0.00435	CcSEcCtD
Amobarbital—Feeling abnormal—Vinblastine—kidney cancer	0.00365	0.00433	CcSEcCtD
Amobarbital—Injection site reaction—Doxorubicin—kidney cancer	0.00365	0.00433	CcSEcCtD
Amobarbital—Constipation—Erlotinib—kidney cancer	0.00364	0.00432	CcSEcCtD
Amobarbital—Feeling abnormal—Everolimus—kidney cancer	0.00363	0.00431	CcSEcCtD
Amobarbital—Shock—Sunitinib—kidney cancer	0.00362	0.0043	CcSEcCtD
Amobarbital—Vomiting—Pazopanib—kidney cancer	0.00355	0.00421	CcSEcCtD
Amobarbital—Bradycardia—Paclitaxel—kidney cancer	0.00354	0.00421	CcSEcCtD
Amobarbital—Rash—Pazopanib—kidney cancer	0.00352	0.00418	CcSEcCtD
Amobarbital—Nausea—Temsirolimus—kidney cancer	0.00352	0.00418	CcSEcCtD
Amobarbital—Dermatitis—Pazopanib—kidney cancer	0.00352	0.00418	CcSEcCtD
Amobarbital—Agitation—Vincristine—kidney cancer	0.00351	0.00416	CcSEcCtD
Amobarbital—Headache—Pazopanib—kidney cancer	0.0035	0.00415	CcSEcCtD
Amobarbital—Body temperature increased—Everolimus—kidney cancer	0.00348	0.00414	CcSEcCtD
Amobarbital—Body temperature increased—Erlotinib—kidney cancer	0.00336	0.00399	CcSEcCtD
Amobarbital—Nausea—Pazopanib—kidney cancer	0.00332	0.00394	CcSEcCtD
Amobarbital—Constipation—Sorafenib—kidney cancer	0.00327	0.00388	CcSEcCtD
Amobarbital—Hypersensitivity—Vinblastine—kidney cancer	0.00326	0.00387	CcSEcCtD
Amobarbital—Hypersensitivity—Everolimus—kidney cancer	0.00325	0.00386	CcSEcCtD
Amobarbital—Mental disability—Doxorubicin—kidney cancer	0.00318	0.00378	CcSEcCtD
Amobarbital—Constipation—Sunitinib—kidney cancer	0.00315	0.00374	CcSEcCtD
Amobarbital—Body temperature increased—Sorafenib—kidney cancer	0.00302	0.00359	CcSEcCtD
Amobarbital—Tension—Paclitaxel—kidney cancer	0.00297	0.00353	CcSEcCtD
Amobarbital—Nervousness—Paclitaxel—kidney cancer	0.00294	0.00349	CcSEcCtD
Amobarbital—Dizziness—Vinblastine—kidney cancer	0.00293	0.00347	CcSEcCtD
Amobarbital—Dizziness—Everolimus—kidney cancer	0.00291	0.00346	CcSEcCtD
Amobarbital—Body temperature increased—Sunitinib—kidney cancer	0.00291	0.00346	CcSEcCtD
Amobarbital—Hypotension—Vincristine—kidney cancer	0.00291	0.00345	CcSEcCtD
Amobarbital—Bradycardia—Capecitabine—kidney cancer	0.00291	0.00345	CcSEcCtD
Amobarbital—Feeling abnormal—Dactinomycin—kidney cancer	0.00287	0.00341	CcSEcCtD
Amobarbital—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.00282	0.00335	CcSEcCtD
Amobarbital—Hypersensitivity—Sorafenib—kidney cancer	0.00282	0.00335	CcSEcCtD
Amobarbital—Vomiting—Vinblastine—kidney cancer	0.00281	0.00334	CcSEcCtD
Amobarbital—Dizziness—Erlotinib—kidney cancer	0.00281	0.00334	CcSEcCtD
Amobarbital—Vomiting—Everolimus—kidney cancer	0.0028	0.00333	CcSEcCtD
Amobarbital—Agitation—Paclitaxel—kidney cancer	0.00278	0.00331	CcSEcCtD
Amobarbital—Rash—Everolimus—kidney cancer	0.00278	0.0033	CcSEcCtD
Amobarbital—Dermatitis—Everolimus—kidney cancer	0.00278	0.0033	CcSEcCtD
Amobarbital—Headache—Vinblastine—kidney cancer	0.00277	0.00329	CcSEcCtD
Amobarbital—Angioedema—Paclitaxel—kidney cancer	0.00277	0.00329	CcSEcCtD
Amobarbital—Headache—Everolimus—kidney cancer	0.00276	0.00328	CcSEcCtD
Amobarbital—Hypotension—Gemcitabine—kidney cancer	0.00276	0.00328	CcSEcCtD
Amobarbital—Body temperature increased—Dactinomycin—kidney cancer	0.00276	0.00327	CcSEcCtD
Amobarbital—Syncope—Paclitaxel—kidney cancer	0.00272	0.00323	CcSEcCtD
Amobarbital—Hypersensitivity—Sunitinib—kidney cancer	0.00271	0.00322	CcSEcCtD
Amobarbital—Vomiting—Erlotinib—kidney cancer	0.0027	0.00321	CcSEcCtD
Amobarbital—Rash—Erlotinib—kidney cancer	0.00268	0.00318	CcSEcCtD
Amobarbital—Dermatitis—Erlotinib—kidney cancer	0.00268	0.00318	CcSEcCtD
Amobarbital—Headache—Erlotinib—kidney cancer	0.00266	0.00316	CcSEcCtD
Amobarbital—Loss of consciousness—Paclitaxel—kidney cancer	0.00266	0.00316	CcSEcCtD
Amobarbital—Constipation—Vincristine—kidney cancer	0.00266	0.00316	CcSEcCtD
Amobarbital—Nausea—Vinblastine—kidney cancer	0.00263	0.00312	CcSEcCtD
Amobarbital—Somnolence—Gemcitabine—kidney cancer	0.00263	0.00312	CcSEcCtD
Amobarbital—Nausea—Everolimus—kidney cancer	0.00262	0.00311	CcSEcCtD
Amobarbital—Anxiety—Paclitaxel—kidney cancer	0.00257	0.00305	CcSEcCtD
Amobarbital—Hypersensitivity—Dactinomycin—kidney cancer	0.00257	0.00305	CcSEcCtD
Amobarbital—Dizziness—Sorafenib—kidney cancer	0.00253	0.003	CcSEcCtD
Amobarbital—Constipation—Gemcitabine—kidney cancer	0.00253	0.003	CcSEcCtD
Amobarbital—Nausea—Erlotinib—kidney cancer	0.00253	0.003	CcSEcCtD
Amobarbital—Ataxia—Doxorubicin—kidney cancer	0.0025	0.00297	CcSEcCtD
Amobarbital—Confusional state—Paclitaxel—kidney cancer	0.00249	0.00296	CcSEcCtD
Amobarbital—Body temperature increased—Vincristine—kidney cancer	0.00246	0.00292	CcSEcCtD
Amobarbital—Dizziness—Sunitinib—kidney cancer	0.00243	0.00289	CcSEcCtD
Amobarbital—Feeling abnormal—Gemcitabine—kidney cancer	0.00243	0.00289	CcSEcCtD
Amobarbital—Shock—Paclitaxel—kidney cancer	0.00243	0.00289	CcSEcCtD
Amobarbital—Vomiting—Sorafenib—kidney cancer	0.00243	0.00289	CcSEcCtD
Amobarbital—Rash—Sorafenib—kidney cancer	0.00241	0.00286	CcSEcCtD
Amobarbital—Dermatitis—Sorafenib—kidney cancer	0.00241	0.00286	CcSEcCtD
Amobarbital—Headache—Sorafenib—kidney cancer	0.0024	0.00285	CcSEcCtD
Amobarbital—Vomiting—Sunitinib—kidney cancer	0.00234	0.00278	CcSEcCtD
Amobarbital—Body temperature increased—Gemcitabine—kidney cancer	0.00234	0.00277	CcSEcCtD
Amobarbital—Rash—Sunitinib—kidney cancer	0.00232	0.00276	CcSEcCtD
Amobarbital—Dermatitis—Sunitinib—kidney cancer	0.00232	0.00275	CcSEcCtD
Amobarbital—Hypotension—Paclitaxel—kidney cancer	0.00231	0.00274	CcSEcCtD
Amobarbital—Headache—Sunitinib—kidney cancer	0.00231	0.00274	CcSEcCtD
Amobarbital—Hypersensitivity—Vincristine—kidney cancer	0.00229	0.00272	CcSEcCtD
Amobarbital—Nausea—Sorafenib—kidney cancer	0.00227	0.0027	CcSEcCtD
Amobarbital—Syncope—Capecitabine—kidney cancer	0.00223	0.00265	CcSEcCtD
Amobarbital—Vomiting—Dactinomycin—kidney cancer	0.00222	0.00263	CcSEcCtD
Amobarbital—Somnolence—Paclitaxel—kidney cancer	0.0022	0.00261	CcSEcCtD
Amobarbital—Rash—Dactinomycin—kidney cancer	0.0022	0.00261	CcSEcCtD
Amobarbital—Nausea—Sunitinib—kidney cancer	0.00219	0.0026	CcSEcCtD
Amobarbital—Loss of consciousness—Capecitabine—kidney cancer	0.00219	0.0026	CcSEcCtD
Amobarbital—Constipation—Paclitaxel—kidney cancer	0.00212	0.00251	CcSEcCtD
Amobarbital—Anxiety—Capecitabine—kidney cancer	0.00211	0.00251	CcSEcCtD
Amobarbital—Nausea—Dactinomycin—kidney cancer	0.00207	0.00246	CcSEcCtD
Amobarbital—Dizziness—Vincristine—kidney cancer	0.00206	0.00244	CcSEcCtD
Amobarbital—Confusional state—Capecitabine—kidney cancer	0.00205	0.00243	CcSEcCtD
Amobarbital—Feeling abnormal—Paclitaxel—kidney cancer	0.00204	0.00242	CcSEcCtD
Amobarbital—Shock—Capecitabine—kidney cancer	0.002	0.00237	CcSEcCtD
Amobarbital—Vomiting—Vincristine—kidney cancer	0.00198	0.00235	CcSEcCtD
Amobarbital—Rash—Vincristine—kidney cancer	0.00196	0.00233	CcSEcCtD
Amobarbital—Dermatitis—Vincristine—kidney cancer	0.00196	0.00233	CcSEcCtD
Amobarbital—Body temperature increased—Paclitaxel—kidney cancer	0.00196	0.00232	CcSEcCtD
Amobarbital—Headache—Vincristine—kidney cancer	0.00195	0.00232	CcSEcCtD
Amobarbital—Hypotension—Capecitabine—kidney cancer	0.0019	0.00225	CcSEcCtD
Amobarbital—Vomiting—Gemcitabine—kidney cancer	0.00188	0.00223	CcSEcCtD
Amobarbital—Bradycardia—Doxorubicin—kidney cancer	0.00187	0.00223	CcSEcCtD
Amobarbital—Rash—Gemcitabine—kidney cancer	0.00186	0.00221	CcSEcCtD
Amobarbital—Dermatitis—Gemcitabine—kidney cancer	0.00186	0.00221	CcSEcCtD
Amobarbital—Headache—Gemcitabine—kidney cancer	0.00185	0.0022	CcSEcCtD
Amobarbital—Nausea—Vincristine—kidney cancer	0.00185	0.0022	CcSEcCtD
Amobarbital—Hypersensitivity—Paclitaxel—kidney cancer	0.00182	0.00216	CcSEcCtD
Amobarbital—Nausea—Gemcitabine—kidney cancer	0.00175	0.00208	CcSEcCtD
Amobarbital—Constipation—Capecitabine—kidney cancer	0.00174	0.00206	CcSEcCtD
Amobarbital—Feeling abnormal—Capecitabine—kidney cancer	0.00167	0.00199	CcSEcCtD
Amobarbital—Dizziness—Paclitaxel—kidney cancer	0.00164	0.00194	CcSEcCtD
Amobarbital—Body temperature increased—Capecitabine—kidney cancer	0.0016	0.00191	CcSEcCtD
Amobarbital—Tension—Doxorubicin—kidney cancer	0.00157	0.00187	CcSEcCtD
Amobarbital—Vomiting—Paclitaxel—kidney cancer	0.00157	0.00187	CcSEcCtD
Amobarbital—Rash—Paclitaxel—kidney cancer	0.00156	0.00185	CcSEcCtD
Amobarbital—Dermatitis—Paclitaxel—kidney cancer	0.00156	0.00185	CcSEcCtD
Amobarbital—Nervousness—Doxorubicin—kidney cancer	0.00156	0.00185	CcSEcCtD
Amobarbital—Headache—Paclitaxel—kidney cancer	0.00155	0.00184	CcSEcCtD
Amobarbital—Hypersensitivity—Capecitabine—kidney cancer	0.0015	0.00178	CcSEcCtD
Amobarbital—Agitation—Doxorubicin—kidney cancer	0.00147	0.00175	CcSEcCtD
Amobarbital—Nausea—Paclitaxel—kidney cancer	0.00147	0.00174	CcSEcCtD
Amobarbital—Syncope—Doxorubicin—kidney cancer	0.00144	0.00171	CcSEcCtD
Amobarbital—Loss of consciousness—Doxorubicin—kidney cancer	0.00141	0.00167	CcSEcCtD
Amobarbital—Anxiety—Doxorubicin—kidney cancer	0.00136	0.00161	CcSEcCtD
Amobarbital—Dizziness—Capecitabine—kidney cancer	0.00134	0.00159	CcSEcCtD
Amobarbital—Confusional state—Doxorubicin—kidney cancer	0.00132	0.00157	CcSEcCtD
Amobarbital—Vomiting—Capecitabine—kidney cancer	0.00129	0.00153	CcSEcCtD
Amobarbital—Shock—Doxorubicin—kidney cancer	0.00129	0.00153	CcSEcCtD
Amobarbital—Rash—Capecitabine—kidney cancer	0.00128	0.00152	CcSEcCtD
Amobarbital—Dermatitis—Capecitabine—kidney cancer	0.00128	0.00152	CcSEcCtD
Amobarbital—Headache—Capecitabine—kidney cancer	0.00127	0.00151	CcSEcCtD
Amobarbital—Hypotension—Doxorubicin—kidney cancer	0.00122	0.00145	CcSEcCtD
Amobarbital—Nausea—Capecitabine—kidney cancer	0.00121	0.00143	CcSEcCtD
Amobarbital—Somnolence—Doxorubicin—kidney cancer	0.00116	0.00138	CcSEcCtD
Amobarbital—Constipation—Doxorubicin—kidney cancer	0.00112	0.00133	CcSEcCtD
Amobarbital—Feeling abnormal—Doxorubicin—kidney cancer	0.00108	0.00128	CcSEcCtD
Amobarbital—Body temperature increased—Doxorubicin—kidney cancer	0.00103	0.00123	CcSEcCtD
Amobarbital—Hypersensitivity—Doxorubicin—kidney cancer	0.000964	0.00114	CcSEcCtD
Amobarbital—Dizziness—Doxorubicin—kidney cancer	0.000865	0.00103	CcSEcCtD
Amobarbital—Vomiting—Doxorubicin—kidney cancer	0.000832	0.000988	CcSEcCtD
Amobarbital—Rash—Doxorubicin—kidney cancer	0.000825	0.000979	CcSEcCtD
Amobarbital—Dermatitis—Doxorubicin—kidney cancer	0.000824	0.000979	CcSEcCtD
Amobarbital—Headache—Doxorubicin—kidney cancer	0.00082	0.000973	CcSEcCtD
Amobarbital—Nausea—Doxorubicin—kidney cancer	0.000777	0.000923	CcSEcCtD
Amobarbital—GABRA4—Neuronal System—KCNMA1—kidney cancer	0.000643	0.00408	CbGpPWpGaD
Amobarbital—CHRNA4—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000639	0.00405	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000634	0.00402	CbGpPWpGaD
Amobarbital—GABRA6—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000629	0.00399	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000623	0.00395	CbGpPWpGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000621	0.00394	CbGpPWpGaD
Amobarbital—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000605	0.00384	CbGpPWpGaD
Amobarbital—CHRNA7—Neuronal System—BCHE—kidney cancer	0.0006	0.00381	CbGpPWpGaD
Amobarbital—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000597	0.00379	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000589	0.00373	CbGpPWpGaD
Amobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000585	0.00371	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—ACHE—kidney cancer	0.000579	0.00367	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—KCNMA1—kidney cancer	0.000571	0.00362	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—IL13—kidney cancer	0.000564	0.00357	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—ACHE—kidney cancer	0.000562	0.00356	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—KCNMA1—kidney cancer	0.000561	0.00356	CbGpPWpGaD
Amobarbital—GABRA5—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000552	0.0035	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—KCNMA1—kidney cancer	0.000552	0.0035	CbGpPWpGaD
Amobarbital—GABRA6—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000548	0.00347	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000542	0.00343	CbGpPWpGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000541	0.00343	CbGpPWpGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000532	0.00338	CbGpPWpGaD
Amobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000532	0.00337	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000531	0.00337	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—TSC2—kidney cancer	0.000527	0.00334	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—BCHE—kidney cancer	0.000505	0.0032	CbGpPWpGaD
Amobarbital—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000491	0.00311	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—BCHE—kidney cancer	0.000489	0.0031	CbGpPWpGaD
Amobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000488	0.0031	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—ACHE—kidney cancer	0.000482	0.00305	CbGpPWpGaD
Amobarbital—GABRA5—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000481	0.00305	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.00048	0.00304	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—ACHE—kidney cancer	0.000476	0.00302	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000472	0.00299	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—KCNMA1—kidney cancer	0.00047	0.00298	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—APC—kidney cancer	0.000465	0.00295	CbGpPWpGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000464	0.00294	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000454	0.00288	CbGpPWpGaD
Amobarbital—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000451	0.00286	CbGpPWpGaD
Amobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000447	0.00283	CbGpPWpGaD
Amobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000444	0.00282	CbGpPWpGaD
Amobarbital—GRIK2—Transmission across Chemical Synapses—BRAF—kidney cancer	0.00044	0.00279	CbGpPWpGaD
Amobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000434	0.00275	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—GSTT1—kidney cancer	0.000432	0.00274	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.000427	0.00271	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—SLC5A5—kidney cancer	0.000424	0.00269	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—ACHE—kidney cancer	0.000423	0.00268	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000423	0.00268	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000423	0.00268	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000423	0.00268	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—BCHE—kidney cancer	0.00042	0.00266	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000417	0.00265	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000417	0.00265	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000417	0.00265	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—ACHE—kidney cancer	0.000415	0.00263	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—BCHE—kidney cancer	0.000414	0.00263	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—SLC2A1—kidney cancer	0.000409	0.00259	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—ACHE—kidney cancer	0.000408	0.00259	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—PTGS1—kidney cancer	0.000405	0.00256	CbGpPWpGaD
Amobarbital—CHRNA7—Transmission across Chemical Synapses—BRAF—kidney cancer	0.0004	0.00254	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000396	0.00251	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—EGR1—kidney cancer	0.00038	0.00241	CbGpPWpGaD
Amobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000373	0.00237	CbGpPWpGaD
Amobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000372	0.00236	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000371	0.00235	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000371	0.00235	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000371	0.00235	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—BCHE—kidney cancer	0.000368	0.00233	CbGpPWpGaD
Amobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000367	0.00233	CbGpPWpGaD
Amobarbital—GRIK2—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000367	0.00233	CbGpPWpGaD
Amobarbital—CYP2A6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000366	0.00232	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—RAF1—kidney cancer	0.000365	0.00231	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000364	0.00231	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000364	0.00231	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000364	0.00231	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—RELA—kidney cancer	0.000363	0.0023	CbGpPWpGaD
Amobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000362	0.0023	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—BCHE—kidney cancer	0.000362	0.00229	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000358	0.00227	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000358	0.00227	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000358	0.00227	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—MTOR—kidney cancer	0.000356	0.00226	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—BCHE—kidney cancer	0.000355	0.00225	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000355	0.00225	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000353	0.00224	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—ACHE—kidney cancer	0.000348	0.00221	CbGpPWpGaD
Amobarbital—CYP2A6—Fluoropyrimidine Activity—TP53—kidney cancer	0.000346	0.00219	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—GSTP1—kidney cancer	0.000341	0.00216	CbGpPWpGaD
Amobarbital—GRIK2—Neuronal System—BRAF—kidney cancer	0.000337	0.00214	CbGpPWpGaD
Amobarbital—GRIA2—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000336	0.00213	CbGpPWpGaD
Amobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000335	0.00212	CbGpPWpGaD
Amobarbital—CHRNA7—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000334	0.00212	CbGpPWpGaD
Amobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000326	0.00207	CbGpPWpGaD
Amobarbital—CHRNA4—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000326	0.00207	CbGpPWpGaD
Amobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.00032	0.00203	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—JUN—kidney cancer	0.000318	0.00202	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—CTNNB1—kidney cancer	0.000316	0.002	CbGpPWpGaD
Amobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000315	0.002	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—GSTM1—kidney cancer	0.000314	0.00199	CbGpPWpGaD
Amobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000311	0.00197	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.00031	0.00197	CbGpPWpGaD
Amobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000307	0.00194	CbGpPWpGaD
Amobarbital—CHRNA7—Neuronal System—BRAF—kidney cancer	0.000306	0.00194	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000305	0.00193	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000305	0.00193	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000305	0.00193	CbGpPWpGaD
Amobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000305	0.00193	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—BCHE—kidney cancer	0.000303	0.00192	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—GSTP1—kidney cancer	0.000299	0.0019	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000297	0.00188	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—JUN—kidney cancer	0.00029	0.00184	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000287	0.00182	CbGpPWpGaD
Amobarbital—GRIK2—Neuronal System—RAF1—kidney cancer	0.000281	0.00178	CbGpPWpGaD
Amobarbital—GRIA2—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000281	0.00178	CbGpPWpGaD
Amobarbital—GABRA6—Transmission across Chemical Synapses—BRAF—kidney cancer	0.00028	0.00177	CbGpPWpGaD
Amobarbital—GABRA6—Ion channel transport—RAF1—kidney cancer	0.000276	0.00175	CbGpPWpGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000276	0.00175	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—GSTM1—kidney cancer	0.000275	0.00174	CbGpPWpGaD
Amobarbital—GABRA4—Ion channel transport—RAF1—kidney cancer	0.000273	0.00173	CbGpPWpGaD
Amobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000272	0.00173	CbGpPWpGaD
Amobarbital—CHRNA4—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000272	0.00173	CbGpPWpGaD
Amobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000268	0.0017	CbGpPWpGaD
Amobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000268	0.0017	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—MAPK3—kidney cancer	0.000263	0.00167	CbGpPWpGaD
Amobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000263	0.00167	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—CYP1A1—kidney cancer	0.000261	0.00165	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—BRAF—kidney cancer	0.000258	0.00163	CbGpPWpGaD
Amobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000256	0.00162	CbGpPWpGaD
Amobarbital—CHRNA7—Neuronal System—RAF1—kidney cancer	0.000256	0.00162	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000253	0.0016	CbGpPWpGaD
Amobarbital—GRIK2—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000252	0.0016	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—MAPK1—kidney cancer	0.00025	0.00159	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—BRAF—kidney cancer	0.00025	0.00158	CbGpPWpGaD
Amobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000248	0.00157	CbGpPWpGaD
Amobarbital—GABRA5—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000245	0.00155	CbGpPWpGaD
Amobarbital—GABRA5—Ion channel transport—RAF1—kidney cancer	0.000242	0.00154	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000241	0.00153	CbGpPWpGaD
Amobarbital—GABRA3—Ion channel transport—RAF1—kidney cancer	0.000238	0.00151	CbGpPWpGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000237	0.0015	CbGpPWpGaD
Amobarbital—GABRA2—Ion channel transport—RAF1—kidney cancer	0.000234	0.00148	CbGpPWpGaD
Amobarbital—GABRA6—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000233	0.00148	CbGpPWpGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—RAF1—kidney cancer	0.00023	0.00146	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ACY1—kidney cancer	0.000229	0.00145	CbGpPWpGaD
Amobarbital—CHRNA7—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000229	0.00145	CbGpPWpGaD
Amobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000224	0.00142	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000223	0.00141	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.00022	0.0014	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000215	0.00136	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—RAF1—kidney cancer	0.000215	0.00136	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—BRAF—kidney cancer	0.000214	0.00136	CbGpPWpGaD
Amobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000213	0.00135	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000213	0.00135	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—BRAF—kidney cancer	0.000212	0.00134	CbGpPWpGaD
Amobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.00021	0.00133	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—RAF1—kidney cancer	0.000209	0.00132	CbGpPWpGaD
Amobarbital—GABRA5—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000205	0.0013	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000202	0.00128	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000201	0.00127	CbGpPWpGaD
Amobarbital—GABRA1—Ion channel transport—RAF1—kidney cancer	0.000199	0.00126	CbGpPWpGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000198	0.00125	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000196	0.00124	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PDHB—kidney cancer	0.000195	0.00124	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—POMC—kidney cancer	0.000194	0.00123	CbGpPWpGaD
Amobarbital—GRIK2—Neuronal System—MAPK1—kidney cancer	0.000193	0.00122	CbGpPWpGaD
Amobarbital—GRIA2—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000193	0.00122	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000192	0.00122	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000189	0.0012	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000189	0.0012	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—BRAF—kidney cancer	0.000188	0.00119	CbGpPWpGaD
Amobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000187	0.00118	CbGpPWpGaD
Amobarbital—CHRNA4—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000187	0.00118	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000185	0.00118	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—BRAF—kidney cancer	0.000185	0.00117	CbGpPWpGaD
Amobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000183	0.00116	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CCBL1—kidney cancer	0.000183	0.00116	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000182	0.00116	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—BRAF—kidney cancer	0.000181	0.00115	CbGpPWpGaD
Amobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.00018	0.00114	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000179	0.00114	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—RAF1—kidney cancer	0.000179	0.00113	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000178	0.00113	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—RAF1—kidney cancer	0.000177	0.00112	CbGpPWpGaD
Amobarbital—CHRNA7—Neuronal System—MAPK1—kidney cancer	0.000175	0.00111	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.00017	0.00108	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000169	0.00107	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000168	0.00106	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000161	0.00102	CbGpPWpGaD
Amobarbital—GABRA6—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.00016	0.00102	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GLIPR1—kidney cancer	0.000159	0.00101	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PPAT—kidney cancer	0.000159	0.00101	CbGpPWpGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000158	0.001	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—RAF1—kidney cancer	0.000157	0.000995	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000157	0.000993	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000155	0.000985	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—BRAF—kidney cancer	0.000155	0.00098	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—RAF1—kidney cancer	0.000154	0.000977	CbGpPWpGaD
Amobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000154	0.000975	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—RAF1—kidney cancer	0.000151	0.00096	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000149	0.000945	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—APRT—kidney cancer	0.000148	0.000937	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—FH—kidney cancer	0.000148	0.000937	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—MAPK1—kidney cancer	0.000148	0.000935	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000146	0.000928	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000144	0.000912	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—MAPK1—kidney cancer	0.000143	0.000907	CbGpPWpGaD
Amobarbital—GABRA5—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.00014	0.00089	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GPC3—kidney cancer	0.000139	0.000881	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000138	0.000874	CbGpPWpGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000136	0.000859	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CA2—kidney cancer	0.000135	0.000857	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ALAD—kidney cancer	0.000132	0.000835	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—RAF1—kidney cancer	0.000129	0.000819	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ST3GAL2—kidney cancer	0.000129	0.000815	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ALDH1A1—kidney cancer	0.000126	0.000797	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000123	0.000778	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—MAPK1—kidney cancer	0.000123	0.000778	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—MAPK1—kidney cancer	0.000121	0.000768	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SLC5A3—kidney cancer	0.00012	0.000764	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PGK1—kidney cancer	0.00012	0.000764	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—LDHB—kidney cancer	0.000118	0.000749	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000116	0.000733	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—MAPK1—kidney cancer	0.000108	0.000682	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—MAPK1—kidney cancer	0.000106	0.00067	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—MAPK1—kidney cancer	0.000104	0.000658	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CA9—kidney cancer	0.000102	0.000649	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—RAF1—kidney cancer	9.62e-05	0.00061	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—RAF1—kidney cancer	9.5e-05	0.000602	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—MAPK1—kidney cancer	8.86e-05	0.000561	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CRABP1—kidney cancer	8.71e-05	0.000552	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—RAF1—kidney cancer	8.44e-05	0.000535	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—RAF1—kidney cancer	8.28e-05	0.000525	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—RAF1—kidney cancer	8.14e-05	0.000516	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ITPR2—kidney cancer	8.1e-05	0.000513	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTT1—kidney cancer	7.38e-05	0.000468	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ACHE—kidney cancer	7.38e-05	0.000468	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SCARB1—kidney cancer	6.99e-05	0.000443	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—RAF1—kidney cancer	6.94e-05	0.00044	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PTGS1—kidney cancer	6.92e-05	0.000439	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PSMD7—kidney cancer	6.78e-05	0.00043	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—BCHE—kidney cancer	6.43e-05	0.000408	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SLC5A5—kidney cancer	6.35e-05	0.000403	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SLC2A1—kidney cancer	6.14e-05	0.000389	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTP1—kidney cancer	5.12e-05	0.000324	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ABCB1—kidney cancer	4.84e-05	0.000307	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTM1—kidney cancer	4.7e-05	0.000298	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CYP1A1—kidney cancer	4.46e-05	0.000283	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—POMC—kidney cancer	3.32e-05	0.000211	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PTGS2—kidney cancer	2.65e-05	0.000168	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PTEN—kidney cancer	2.31e-05	0.000147	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PIK3CA—kidney cancer	1.63e-05	0.000103	CbGpPWpGaD
